The College of Pharmacy, Center of Drug Evaluation & Safety, in partnership with the Department of Pharmaceutical Outcomes and Policy, would like to welcome Dr. Darren Toh, ScD as our invited guest speaker. He will present his talk, entitled: “Hydrochlorothiazide Use and Risk of Non-Melanoma Skin Cancer”
Please join us Friday, 03/06/2020 from 12:30pm to 1:30pm in HPNP G301-A.
Darren Toh, ScD is an Associate Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute. He is a pharmacoepidemiologist with an interest in the comparative safety and effectiveness research of medical products. His research focuses on 1) assessing the risks and benefits of medical products using electronic data collected as part of routine healthcare delivery, and 2) developing and applying privacy-protecting analytic methods to conduct multi-center studies in distributed data networks.
Dr. Toh is also Chief Scientist at the Operations Center of the FDA-funded Sentinel System, a congressionally mandated national medical product safety surveillance system. He is Principal Investigator of projects funded by the National Institutes of Health, the Agency for Healthcare Research and Quality, the Patient-Centered Outcomes Research Institute, and the Food and Drug Administration. He received his doctoral degree in Epidemiology from the Harvard School of Public Health.